CIRM Funded Clinical Trials
Phase 1 Clinical research program for functional cure of HIV with EBT-101, in-vivo gene therapy
Phase 1 Clinical research program for functional cure of HIV with EBT-101, in-vivo gene therapy
Disease Area:
Investigator:
Institution:
CIRM Grant:
Award Value:
$6,852,486
Trial Sponsor:
Excision BioTherapeutics
Trial Stage:
Phase 1
Trial Status:
Recruiting
Targeted Enrollment:
9
ClinicalTrials.gov ID:
